TriSalus Life Sciences, Inc. (TLSI)

NASDAQ: TLSI · Real-Time Price · USD

4.880

-0.120 (-2.40%)

At close: Jul 11, 2025, 4:00 PM

4.890

+0.010 (0.20%)

After-hours: Jul 11, 2025, 4:04 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
Innovative Drug Delivery Technology and Immune-oncology Therapeutics	18.51M

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
United States	18.51M